foy 251 has been researched along with camostat mesylate in 1 studies
| Studies (foy 251) | Trials (foy 251) | Recent Studies (post-2010) (foy 251) | Studies (camostat mesylate) | Trials (camostat mesylate) | Recent Studies (post-2010) (camostat mesylate) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 10 | 0 | 8 |
| Protein | Taxonomy | foy 251 (IC50) | camostat mesylate (IC50) |
|---|---|---|---|
| Trypsin-1 | Homo sapiens (human) | 0.0506 | |
| Plasminogen | Rattus norvegicus (Norway rat) | 2.62 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Kamiyasu, K; Kato, M; Maruyama, T; Miyazaki, T; Nakai, H; Nakayama, Y; Odagaki, Y; Sakaki, K; Senokuchi, K | 1 |
1 other study(ies) available for foy 251 and camostat mesylate
| Article | Year |
|---|---|
New orally active serine protease inhibitors.
Topics: Administration, Oral; Amino Acid Sequence; Animals; Benzamidines; Dogs; Molecular Sequence Data; Rats; Serine Proteinase Inhibitors | 1995 |